Skip to main content
Erschienen in: Journal of Neurology 1/2016

01.01.2016 | Review

A systematic review of loss of independence in Parkinson’s disease

verfasst von: Angus D. Macleod, J. W. Kerr Grieve, Carl E. Counsell

Erschienen in: Journal of Neurology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Functional dependency (needing help with basic ADLs) is an important outcome in Parkinson’s disease (PD). “Death or dependency”, as opposed to being alive and independent, is a useful dichotomous indicator of poor outcome. We aimed to systematically review the progression to dependency in PD and what factors predicted development of dependency. Comprehensive searches were performed to identify observational studies of dependency in PD with follow-up of at least 3 years. Other forms of parkinsonism and highly selected cohorts were excluded. Descriptive analysis of included studies was performed and outcomes over time were plotted by type of cohort (inception/non-inception). Independent prognostic factors were identified. There were insufficient data for meta-analysis. Of 15,154 unique references identified, 14 studies were included. Most studies were of low quality. There was heterogeneity in definitions of dependency and the measured risk of dependency at similar time-points. Risk of dependency in inception studies was about 10–25 % at 5 years and about 20–50 % at 10 years; and risk of “death or dependency” in the inception studies was about 15–40 % at 5 years and about 35–70 % at ten years. More bradykinesia and older age were associated with more dependency, but there was little evidence for other prognostic factors. Few high-quality data on dependency are available. Heterogeneity in study populations, methodology and outcome reporting made data synthesis difficult. Few prognostic factors have been identified. Further data from representative inception studies are necessary to better understand the progression of dependency in PD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat World Health Organization (1980) International classification of impairments, disabilities, and handicaps. World Health Organization, Geneva World Health Organization (1980) International classification of impairments, disabilities, and handicaps. World Health Organization, Geneva
2.
Zurück zum Zitat World Health Organization (2002) Towards a common language for functioning, disability and health. World Health Organization, Geneva World Health Organization (2002) Towards a common language for functioning, disability and health. World Health Organization, Geneva
3.
Zurück zum Zitat Schwab RS, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson MC (eds) Third symposium on Parkinson’s disease. E & S Livingston, Edinburgh, pp 152–157 Schwab RS, England AC (1969) Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson MC (eds) Third symposium on Parkinson’s disease. E & S Livingston, Edinburgh, pp 152–157
4.
Zurück zum Zitat Wade DT, Collin C (1988) The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 10(2):64–67CrossRefPubMed Wade DT, Collin C (1988) The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 10(2):64–67CrossRefPubMed
5.
Zurück zum Zitat Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17(5):427–442CrossRefPubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17(5):427–442CrossRefPubMed
6.
Zurück zum Zitat Marras C, Rochon P, Lang AE (2002) Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol 59(11):1724–1728CrossRefPubMed Marras C, Rochon P, Lang AE (2002) Predicting motor decline and disability in Parkinson disease: a systematic review. Arch Neurol 59(11):1724–1728CrossRefPubMed
7.
Zurück zum Zitat Post B, Merkus MP, de Haan RJ, Speelman JD, Group CS (2007) Prognostic factors for the progression of Parkinson’s disease: a systematic review. Mov Disord 22(13):1839–1851 Post B, Merkus MP, de Haan RJ, Speelman JD, Group CS (2007) Prognostic factors for the progression of Parkinson’s disease: a systematic review. Mov Disord 22(13):1839–1851
10.
Zurück zum Zitat Chia LG, Liu LH (1992) Parkinson’s disease in Taiwan: an analysis of 215 patients. Neuroepidemiology 11(3):113–120CrossRefPubMed Chia LG, Liu LH (1992) Parkinson’s disease in Taiwan: an analysis of 215 patients. Neuroepidemiology 11(3):113–120CrossRefPubMed
11.
Zurück zum Zitat Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844CrossRefPubMed Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837–844CrossRefPubMed
12.
Zurück zum Zitat Hoehn MM (1985) Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson’s disease. Acta Neurol Scand 71(2):97–106CrossRefPubMed Hoehn MM (1985) Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson’s disease. Acta Neurol Scand 71(2):97–106CrossRefPubMed
13.
Zurück zum Zitat Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ (2012) Loss of ability to work and ability to live independently in Parkinson’s disease. Parkinsonism Relat Disord 18(2):130–135PubMedCentralCrossRefPubMed Jasinska-Myga B, Heckman MG, Wider C, Putzke JD, Wszolek ZK, Uitti RJ (2012) Loss of ability to work and ability to live independently in Parkinson’s disease. Parkinsonism Relat Disord 18(2):130–135PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N, Mochizuki H, Hattori N, Mori H, Mizuno Y, Juntendo Parkinson Study G (2006) Prognosis of Parkinson’s disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21(9):1384–1395 Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N, Mochizuki H, Hattori N, Mori H, Mizuno Y, Juntendo Parkinson Study G (2006) Prognosis of Parkinson’s disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21(9):1384–1395
15.
Zurück zum Zitat Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, Obrien PC (1993) Levodopa therapy and survival in idiopathic Parkinsons-Disease—Olmsted County Project. Neurology 43(10):1918–1926CrossRefPubMed Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, Obrien PC (1993) Levodopa therapy and survival in idiopathic Parkinsons-Disease—Olmsted County Project. Neurology 43(10):1918–1926CrossRefPubMed
16.
Zurück zum Zitat Velseboer DC, Broeders M, Post B, van Geloven N, Speelman JD, Schmand B, de Haan RJ, de Bie RM, Group CS (2013) Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology 80(7):627–633 Velseboer DC, Broeders M, Post B, van Geloven N, Speelman JD, Schmand B, de Haan RJ, de Bie RM, Group CS (2013) Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD. Neurology 80(7):627–633
17.
Zurück zum Zitat Scigliano G, Musicco M, Soliveri P, Girotti F, Giovannini P, Fetoni V, Caraceni T (1996) Progression and prognosis in Parkinson’s disease in relation to concomitant cerebral or peripheral vasculopathy. Adv Neurol 69:305–309PubMed Scigliano G, Musicco M, Soliveri P, Girotti F, Giovannini P, Fetoni V, Caraceni T (1996) Progression and prognosis in Parkinson’s disease in relation to concomitant cerebral or peripheral vasculopathy. Adv Neurol 69:305–309PubMed
18.
Zurück zum Zitat Aimard G, Henry E, Devic M (1984) Parkinson’s disease. Retrospective study of 302 clinical case records. Presse Med 13(15):919–922PubMed Aimard G, Henry E, Devic M (1984) Parkinson’s disease. Retrospective study of 302 clinical case records. Presse Med 13(15):919–922PubMed
19.
Zurück zum Zitat Auyeung M, Tsoi TH, Mok V, Cheung CM, Lee CN, Li R, Yeung E (2012) Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry 83(6):607–611CrossRefPubMed Auyeung M, Tsoi TH, Mok V, Cheung CM, Lee CN, Li R, Yeung E (2012) Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson’s disease patients. J Neurol Neurosurg Psychiatry 83(6):607–611CrossRefPubMed
20.
Zurück zum Zitat Guillard A, Chastang C, Fenelon G (1986) Long-term study of 416 cases of Parkinson disease. Prognostic factors and therapeutic implications. Rev Neurol (Paris) 142(3):207–214 Guillard A, Chastang C, Fenelon G (1986) Long-term study of 416 cases of Parkinson disease. Prognostic factors and therapeutic implications. Rev Neurol (Paris) 142(3):207–214
21.
Zurück zum Zitat Yahr MD (1976) Evaluation of long-term therapy in Parkinson’s disease: mortality and therapeutic efficacy. In: Birkmayer W, Hornykiewicz O (eds) Advances in Parkinsonism. Editiones Roche, Basle, pp 435–443 Yahr MD (1976) Evaluation of long-term therapy in Parkinson’s disease: mortality and therapeutic efficacy. In: Birkmayer W, Hornykiewicz O (eds) Advances in Parkinsonism. Editiones Roche, Basle, pp 435–443
22.
Zurück zum Zitat Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73(3):206–212CrossRefPubMed Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology 73(3):206–212CrossRefPubMed
23.
Zurück zum Zitat Laupacis A, Wells G, Richardson WS, Tugwell P (1994) Users’ guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 272(3):234–237CrossRefPubMed Laupacis A, Wells G, Richardson WS, Tugwell P (1994) Users’ guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 272(3):234–237CrossRefPubMed
25.
Zurück zum Zitat Rybicki BA, Johnson CC, Gorell JM (1995) Demographic differences in referral rates to neurologists of patients with suspected Parkinson’s disease: implications for case-control study design. Neuroepidemiology 14(2):72–81CrossRefPubMed Rybicki BA, Johnson CC, Gorell JM (1995) Demographic differences in referral rates to neurologists of patients with suspected Parkinson’s disease: implications for case-control study design. Neuroepidemiology 14(2):72–81CrossRefPubMed
26.
Zurück zum Zitat Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA (2011) The natural history of treated Parkinson’s disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 82(10):1112–1118CrossRefPubMed Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA (2011) The natural history of treated Parkinson’s disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 82(10):1112–1118CrossRefPubMed
27.
Zurück zum Zitat Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851–857. doi:10.1136/jnnp.2008.168211 CrossRefPubMed Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP (2009) Incidence of Parkinson’s disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 80(8):851–857. doi:10.​1136/​jnnp.​2008.​168211 CrossRefPubMed
28.
Zurück zum Zitat Caslake R, Taylor K, Scott N, Gordon J, Harris C, Wilde K, Murray A, Counsell C (2013) Age-, gender-, and socioeconomic status-specific incidence of Parkinson’s disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism Relat Disord 19(5):515–521. doi:10.1016/j.parkreldis.2013.01.014 CrossRefPubMed Caslake R, Taylor K, Scott N, Gordon J, Harris C, Wilde K, Murray A, Counsell C (2013) Age-, gender-, and socioeconomic status-specific incidence of Parkinson’s disease and parkinsonism in northeast Scotland: the PINE study. Parkinsonism Relat Disord 19(5):515–521. doi:10.​1016/​j.​parkreldis.​2013.​01.​014 CrossRefPubMed
29.
30.
Zurück zum Zitat Herlofson K, Lie SA, Arsland D, Larsen JP (2004) Mortality and Parkinson disease—a community based study. Neurology 62(6):937–942CrossRefPubMed Herlofson K, Lie SA, Arsland D, Larsen JP (2004) Mortality and Parkinson disease—a community based study. Neurology 62(6):937–942CrossRefPubMed
31.
Zurück zum Zitat Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, Briggs A, Udumyan R, Moons KGM, Steyerberg EW, Roberts I, Schroter S, Altman DG, Riley RD (2013) Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 346:e5595–e5595. doi:10.1136/bmj.e5595 PubMedCentralCrossRefPubMed Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, Briggs A, Udumyan R, Moons KGM, Steyerberg EW, Roberts I, Schroter S, Altman DG, Riley RD (2013) Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ 346:e5595–e5595. doi:10.​1136/​bmj.​e5595 PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17(5):867–876. doi:10.1002/mds.10248 CrossRefPubMed Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17(5):867–876. doi:10.​1002/​mds.​10248 CrossRefPubMed
33.
Zurück zum Zitat Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19(9):1020–1028. doi:10.1002/mds.20213 CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19(9):1020–1028. doi:10.​1002/​mds.​20213 CrossRefPubMed
Metadaten
Titel
A systematic review of loss of independence in Parkinson’s disease
verfasst von
Angus D. Macleod
J. W. Kerr Grieve
Carl E. Counsell
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 1/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7847-8

Weitere Artikel der Ausgabe 1/2016

Journal of Neurology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.